Lifemark in $10m US Court of Appeal row

Laura Miller
clock

Lifemark, the cash strapped Luxembourg-based backer of Keydata bonds, is embroiled in a multi-millon dollar legal battle in the US Court of Appeal.

The row is over a $10m US traded life-settlement policy - the asset class which underlies the Lifemark fund - bought by the company in 2007 for $1.9m. American attorney Arthur Kramer bought several policies late in his life, assigned them to two trusts, named his children as beneficiaries and then directed them to sell their interest in the trusts to investors for cash. Following his death, Kramer's widow Alice is claiming the death benefits should go to the estate, not Lifemark investors. Investors who filed claims with the insurers have been told the policies are void. The...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Why non-transparent managers are behind most failed acquisitions

Why non-transparent managers are behind most failed acquisitions

‘They don’t understand the importance of culture and cohesion’

Rami Cassis
clock 12 April 2024 • 3 min read
Partner Insight: Understanding the investment universe

Partner Insight: Understanding the investment universe

Invesco
clock 12 April 2024 • 6 min read
FCA issues warning notice to Neil Woodford over liquidity failings

FCA issues warning notice to Neil Woodford over liquidity failings

The firm failed on four accounts between 2018 and 2019

James Baxter-Derrington
clock 11 April 2024 • 2 min read